(CVGW) Calavo Growers - Overview
Sector: Consumer DefensiveIndustry: Food Distribution | Exchange NASDAQ (USA) | Currency USD | Market Cap: 425m | Total Return 11.6% in 12m
Stock: Avocados, Tomatoes, Papayas, Guacamole, Avocado Pulp
Total Rating 51
Risk 78
Buy Signal 0.30
| Risk 5d forecast | |
|---|---|
| Volatility | 45.5% |
| Relative Tail Risk | -16.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -0.12 |
| Character TTM | |
|---|---|
| Beta | 0.420 |
| Beta Downside | 1.382 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.81% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Description: CVGW Calavo Growers February 28, 2026
Calavo Growers, Inc. (NASDAQ: CVGW) sources, packs, and distributes fresh avocados, tomatoes, and papayas, and processes guacamole and other avocado-based products for retailers, food-service operators, and wholesalers worldwide. The business is organized into Fresh (whole fruit) and Prepared (guacamole, avocado pulp) segments, selling under the Calavo brand and a suite of trademarks such as Avo Fresco, Bueno, and RIPE NOW!.
In FY 2023 the company generated $1.57 billion in revenue, with adjusted EBITDA of $120 million and a gross margin of roughly 23%, reflecting strong pricing power as the U.S. avocado price index rose 10% YoY in Q4 2023. Avocado consumption in the United States grew 6% year-over-year, driven by the continued popularity of healthy, convenient snacks and the expansion of plant-based menu offerings. The firm’s same-store sales for the Fresh segment were up 4.5% in the most recent quarter, while guacamole shipments increased 9% as food-service demand surged.
For a deeper look at CVGW’s valuation and outlook, consider checking ValueRay’s analyst resources.
Headlines to watch out for
- Avocado fresh segment sales drive primary revenue growth
- Prepared segment expansion boosts diversified product offerings
- Commodity price volatility impacts fresh produce margins
- Weather events and disease outbreaks threaten crop yields
- Food safety regulations increase operational compliance costs
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 16.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.04 > 1.0 |
| NWC/Revenue: 13.56% < 20% (prev 12.69%; Δ 0.86% < -1%) |
| CFO/TA 0.06 > 3% & CFO 17.3m > Net Income 16.1m |
| Net Debt (-25.3m) to EBITDA (26.5m): -0.96 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.9m) vs 12m ago -0.04% < -2% |
| Gross Margin: 10.24% > 18% (prev 0.11%; Δ 1.01k% > 0.5%) |
| Asset Turnover: 206.4% > 50% (prev 230.3%; Δ -23.85% > 0%) |
| Interest Coverage Ratio: 25.80 > 6 (EBITDA TTM 26.5m / Interest Expense TTM 743k) |
Altman Z'' 2.83
| A: 0.28 (Total Current Assets 152.6m - Total Current Liabilities 69.1m) / Total Assets 298.2m |
| B: 0.08 (Retained Earnings 25.0m / Total Assets 298.2m) |
| C: 0.06 (EBIT TTM 19.2m / Avg Total Assets 298.6m) |
| D: 0.28 (Book Value of Equity 25.0m / Total Liabilities 90.8m) |
| Altman-Z'' Score: 2.83 = A |
Beneish M -2.99
| DSRI: 1.00 (Receivables 42.9m/48.0m, Revenue 616.3m/688.3m) |
| GMI: 1.03 (GM 10.24% / 10.57%) |
| AQI: 1.15 (AQ_t 0.27 / AQ_t-1 0.24) |
| SGI: 0.90 (Revenue 616.3m / 688.3m) |
| TATA: -0.00 (NI 16.1m - CFO 17.3m) / TA 298.2m) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of CVGW shares?
As of March 25, 2026, the stock is trading at USD 25.51 with a total of 223,912 shares traded.
Over the past week, the price has changed by +4.72%, over one month by -3.92%, over three months by +18.46% and over the past year by +11.58%.
Over the past week, the price has changed by +4.72%, over one month by -3.92%, over three months by +18.46% and over the past year by +11.58%.
Is CVGW a buy, sell or hold?
Calavo Growers has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy CVGW.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CVGW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27 | 5.8% |
| Analysts Target Price | 27 | 5.8% |
CVGW Fundamental Data Overview March 22, 2026
P/E Trailing = 26.4333
P/E Forward = 18.6916
P/S = 0.69
P/B = 2.1246
P/EG = 3.4354
Revenue TTM = 616.3m USD
EBIT TTM = 19.2m USD
EBITDA TTM = 26.5m USD
Long Term Debt = 22.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.48m USD (from shortTermDebt, last quarter)
Debt = 22.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -25.3m USD (from netDebt column, last quarter)
Enterprise Value = 400.0m USD (425.2m + Debt 22.4m - CCE 47.7m)
Interest Coverage Ratio = 25.80 (Ebit TTM 19.2m / Interest Expense TTM 743k)
EV/FCF = 27.29x (Enterprise Value 400.0m / FCF TTM 14.7m)
FCF Yield = 3.66% (FCF TTM 14.7m / Enterprise Value 400.0m)
FCF Margin = 2.38% (FCF TTM 14.7m / Revenue TTM 616.3m)
Net Margin = 2.61% (Net Income TTM 16.1m / Revenue TTM 616.3m)
Gross Margin = 10.24% ((Revenue TTM 616.3m - Cost of Revenue TTM 553.1m) / Revenue TTM)
Gross Margin QoQ = 12.43% (prev 9.34%)
Tobins Q-Ratio = 1.34 (Enterprise Value 400.0m / Total Assets 298.2m)
Interest Expense / Debt = 0.58% (Interest Expense 129k / Debt 22.4m)
Taxrate = 37.04% (473k / 1.28m)
NOPAT = 12.1m (EBIT 19.2m * (1 - 37.04%))
Current Ratio = 2.21 (Total Current Assets 152.6m / Total Current Liabilities 69.1m)
Debt / Equity = 0.11 (Debt 22.4m / totalStockholderEquity, last quarter 205.7m)
Debt / EBITDA = -0.96 (Net Debt -25.3m / EBITDA 26.5m)
Debt / FCF = -1.72 (Net Debt -25.3m / FCF TTM 14.7m)
Total Stockholder Equity = 206.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.40% (Net Income 16.1m / Total Assets 298.2m)
RoE = 7.82% (Net Income TTM 16.1m / Total Stockholder Equity 206.0m)
RoCE = 8.39% (EBIT 19.2m / Capital Employed (Equity 206.0m + L.T.Debt 22.4m))
RoIC = 5.86% (NOPAT 12.1m / Invested Capital 206.0m)
WACC = 7.10% (E(425.2m)/V(447.6m) * Re(7.46%) + D(22.4m)/V(447.6m) * Rd(0.58%) * (1-Tc(0.37)))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.09%
[DCF] Terminal Value 75.00% ; FCFF base≈15.9m ; Y1≈10.4m ; Y5≈4.78m
[DCF] Fair Price = 7.76 (EV 113.4m - Net Debt -25.3m = Equity 138.7m / Shares 17.9m; r=7.10% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 32.30 | EPS CAGR: -5.21% | SUE: 0.28 | # QB: 0
Revenue Correlation: -62.54 | Revenue CAGR: -23.36% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.35 | Chg7d=+0.005 | Chg30d=-0.035 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-10-31): EPS=1.41 | Chg7d=-0.095 | Chg30d=-0.140 | Revisions Net=-1 | Growth EPS=-13.0% | Growth Revenue=-17.1%
EPS next Year (2027-10-31): EPS=1.52 | Chg7d=+0.030 | Chg30d=-0.080 | Revisions Net=-1 | Growth EPS=+7.8% | Growth Revenue=-3.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 7.9% - Earnings Yield 3.8%)
[Growth] Growth Spread = -33.8% (Analyst -29.6% - Implied 4.1%)
P/E Forward = 18.6916
P/S = 0.69
P/B = 2.1246
P/EG = 3.4354
Revenue TTM = 616.3m USD
EBIT TTM = 19.2m USD
EBITDA TTM = 26.5m USD
Long Term Debt = 22.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.48m USD (from shortTermDebt, last quarter)
Debt = 22.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -25.3m USD (from netDebt column, last quarter)
Enterprise Value = 400.0m USD (425.2m + Debt 22.4m - CCE 47.7m)
Interest Coverage Ratio = 25.80 (Ebit TTM 19.2m / Interest Expense TTM 743k)
EV/FCF = 27.29x (Enterprise Value 400.0m / FCF TTM 14.7m)
FCF Yield = 3.66% (FCF TTM 14.7m / Enterprise Value 400.0m)
FCF Margin = 2.38% (FCF TTM 14.7m / Revenue TTM 616.3m)
Net Margin = 2.61% (Net Income TTM 16.1m / Revenue TTM 616.3m)
Gross Margin = 10.24% ((Revenue TTM 616.3m - Cost of Revenue TTM 553.1m) / Revenue TTM)
Gross Margin QoQ = 12.43% (prev 9.34%)
Tobins Q-Ratio = 1.34 (Enterprise Value 400.0m / Total Assets 298.2m)
Interest Expense / Debt = 0.58% (Interest Expense 129k / Debt 22.4m)
Taxrate = 37.04% (473k / 1.28m)
NOPAT = 12.1m (EBIT 19.2m * (1 - 37.04%))
Current Ratio = 2.21 (Total Current Assets 152.6m / Total Current Liabilities 69.1m)
Debt / Equity = 0.11 (Debt 22.4m / totalStockholderEquity, last quarter 205.7m)
Debt / EBITDA = -0.96 (Net Debt -25.3m / EBITDA 26.5m)
Debt / FCF = -1.72 (Net Debt -25.3m / FCF TTM 14.7m)
Total Stockholder Equity = 206.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.40% (Net Income 16.1m / Total Assets 298.2m)
RoE = 7.82% (Net Income TTM 16.1m / Total Stockholder Equity 206.0m)
RoCE = 8.39% (EBIT 19.2m / Capital Employed (Equity 206.0m + L.T.Debt 22.4m))
RoIC = 5.86% (NOPAT 12.1m / Invested Capital 206.0m)
WACC = 7.10% (E(425.2m)/V(447.6m) * Re(7.46%) + D(22.4m)/V(447.6m) * Rd(0.58%) * (1-Tc(0.37)))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.09%
[DCF] Terminal Value 75.00% ; FCFF base≈15.9m ; Y1≈10.4m ; Y5≈4.78m
[DCF] Fair Price = 7.76 (EV 113.4m - Net Debt -25.3m = Equity 138.7m / Shares 17.9m; r=7.10% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 32.30 | EPS CAGR: -5.21% | SUE: 0.28 | # QB: 0
Revenue Correlation: -62.54 | Revenue CAGR: -23.36% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.35 | Chg7d=+0.005 | Chg30d=-0.035 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-10-31): EPS=1.41 | Chg7d=-0.095 | Chg30d=-0.140 | Revisions Net=-1 | Growth EPS=-13.0% | Growth Revenue=-17.1%
EPS next Year (2027-10-31): EPS=1.52 | Chg7d=+0.030 | Chg30d=-0.080 | Revisions Net=-1 | Growth EPS=+7.8% | Growth Revenue=-3.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 7.9% - Earnings Yield 3.8%)
[Growth] Growth Spread = -33.8% (Analyst -29.6% - Implied 4.1%)